CompanyOverview|NASDAQ:VKTX] Viking Therapeutics Inc. (NASDAQ: VKTX) reported earnings after the market closed on Apr. 23.

Rival drugs from Eli Lilly and Viking Therapeutics also target GIPR ... Piper Sandler analyst Christopher Raymon said this isn't new data — for Amgen. "The most obvious point to us here ...

The Ritz-Carlton Ilma, which boasts a price tag of over £450m ... is set to host 16 arrivals from the Norwegian-flagged liner Viking this year, as part of over 60 scheduled visits between ...

Several cruise lines and tour operators offer itineraries along the world's longest river, including National Geographic-Lindblad Expeditions, Viking ... itinerary. Chris Owen, a travel writer ...

The Minnesota Vikings watched Kirk Cousins walk out the door a year ago. Coming off a torn Achilles tendon, the head of the ...

As previously reported, Northcoast analyst Drew May initiated coverage of Viking Holdings (VIK) with a Buy rating and $51 price target The ...

Barclays analyst Brandt Montour lowered the firm’s price target on Viking Holdings (VIK) to $45 from $46 and keeps an Equal Weight rating on ...

Historian William R. Short rates Viking battle scenes in "The Northman," "Thor," and "How to Train Your Dragon." ...

Oppenheimer lowered the firm’s price target on Viking Therapeutics (VKTX) to $100 from $164 and keeps an Outperform rating on the shares. Despite impressive clinical progress for VK2735 subQ and ...

Morgan Stanley analyst Stephen Grambling lowered the firm’s price target on Viking Holdings (VIK) to $47 from $49 and keeps an Overweight ...

Viking Ocean Cruises and Seabourn Cruise Line are very different cruise providers, even though both fall into the luxury cruise category. Seabourn is considered an ultra-luxury brand with smaller ...